1Ivkovic-Kapicl T, Knezevic-Usaj S, Panjkovie M, et al. The influence of aging on pathologic and immunobiologie parameters of invasire ductal breast carcinoma[ J ]. Vojnosanit Pregl,2006,63 (11 ) : 921-927.
2Soussi T, Beroud C. Assessing TP53 status in human tumours to evaluate clinical outcome [ J ]. Nat Rev Cancer, 2001,1 ( 3 ) : 233- 240.
3Cand AE, Sevine AI, Kocdor MA, et al. Metastatic tumors in the breast: a report of 5 cases and review of the literature [ J ]. Clin Breast Cancer,2007,7(8) : 638-643.
5Norberg T, Klaar S, karl C, et al. Increased p53 mutation f requency during tumor progression-results from a breast cancer cohort[ J]. Cancer Res,2001,61 (22) : 8317-8321.
6Bartek J Iggo R,Gaannon J,et al. Genetic and immunochemieal analysis of mutant p53 in human breast cancer cell lines[ J]. Oncogene,1990,5 (6) : 893499.
7Clegg H, Jtahana K, Zhang Y. Unlocking the Mdm2-p53 loop: ubiquitin is the key[J]. Cell Cycle,2008,7(3) : 287-292.
8Olive KP,Tuveson DA, Ruhe ZC, et al. Mutant p53 gain of function in two mouse models of Li-Fraumeni syndrome [ J ]. Cell, 2004,119(6) : 847-860.
9Lang GA, lwakuma T, Suh YA, et al. Gain of function of a p53 hot spot mutation in a mouse model of Li-Fraumeni syndrome [ J]. Cell,2004,119(6) : 861-872.
7Singletary S E,Allred C,Ashley P,et al.Revision of the American Joint Committee on Cancer staging system for breast cancer[J].J Clin Oncol,2002,20(17):3628-3636.
8Liu C H,Chang S H,Joarder F S,et al.Overexpression of cyclooxygenase-2 is suffeicient to induce tumorigenesis in transgenic mice[J].J Boil Chem,2001,267(21):18563-18569.
9Harris R E,Kasbari S,Farrar W B.Prospective study of nonsteriodal anti-inflammatiory drugs and breast cancer[J].Oncol Rep,1999,6(1):71-73.
10Half E,Tang X M,Gwyn K,et al.Cyclooxygenase-2 expression in human breast cancers and adjacent ductal carcinoma in situ[J].Cancer Res,2002,62(6):1676-1681.
7Massidda B,Sini M,Budroni M,etc.Molecular alterations in key-regulator genes among patients with T4 breast carcinoma[J].BMC Cancer,2010,10:458-468.
8García-Escudero R,Martínez-Cruz AB,Santos M,etc.Gene expression profiling of mouse p53-deficient epidermal carcinoma defines molecular determinants of human cancer malignancy[J].Mol Cancer,2010,9:193-211.
9Noranizah W,Siti-Aishah M A,Munirah M A,etc.Immunohistochemical expression of vascular endothelial growth factor (VEGF) and p53 in breast lesions[J].Clin Ter,2010,161(2):129-137.
10Slingerland JM,Benchimol S.Transforming activity of mutant human p53 alleles[J].J Cell Physiol,1991,148(3):391-395.
